Related Tags >> commercialization biopharmaceutical company FDA Mannkind

chief operating officer News

Most Popular chief operating officer Story

Press Release: Blue Heron Biotechnology Names John Fess CEO

December 4, 2006 — 12:18pm ET | By Maureen Martino

Press Release: Blue Heron Biotechnology Names John Fess CEO

Read more...

chief operating officer Press Releases

Emergent BioSolutions Initiates Pivotal Clinical Trial Evaluating a Three-Dose BioThrax Regimen for Post-Exposure Prophyla
Gilead Sciences to Present at the 2011 Credit Suisse Healthcare Conference on Wednesday, November 9
NeuroCog Trials Appoints Industry Executive Michael Hufford, Ph.D. to Chief Operating Officer
MannKind Corporation to Hold 2011 Third Quarter Financial Results Conference Call on November 3, 2011
CMC Biologics Enters Commercial Supply Agreement with Inspiration Biopharmaceuticals for IB1001

Latest Headlines

ALSO NOTED: Shasun sets up NJ plant; Barrier gets a new CEO; Pharming gains grant; and much more...
January 28, 2008
C&L: Lindsay steps down at Ardana
October 10, 2007
Press Release: Encysive Pharmaceuticals to Cut Workforce, Replaces CEO
June 26, 2007
Press Release: Kenneth M. Bate Named CEO of NitroMed
January 22, 2007
Press Release: Aerovance Announces Positive Results from Phase 2a Trial of Inhaled AEROVANT in Asthma Patients
January 3, 2007
Press Release: Skyepharma Announces FDA Approves Foradil Certihaler
December 17, 2006
C&L: Frost resigns at ImClone
December 5, 2006
Press Release: Blue Heron Biotechnology Names John Fess CEO
December 4, 2006
Press Release: Acorda Therapeutics to Receive Up to $10 Million from Paul Capital Healthcare
November 28, 2006
C&L: Kish new president at RHEI
October 10, 2006
C&L: Robinson leaves Ligand
August 1, 2006
Dyax sent back for more data on DX-88
May 15, 2006
C&L: Alan Lewis to run Novocell
May 2, 2006
C&L: Zook takes helm of AstraZeneca's U.S. operations
September 20, 2005
INEX restructures, lays off workers
June 20, 2005

Paid Research Reports

More Research Reports >>